UIM
REGN icon

USS Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

USS Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Buy
21,035
+805
+4% +$548K 0.05% 243
2026
Q1 		$15.6M Buy
20,230
+915
+5% +$701K 0.06% 164
2025
Q4 		$14.9M Buy
19,315
+1,035
+6% +$703K 0.07% 156
2025
Q3 		$10.3M Hold
18,280
– – 0.05% 218
2025
Q2 		$9.59M Buy
18,280
+78
+0.4% +$43.5K 0.06% 216
2025
Q1 		$11.5M Hold
18,202
– – 0.08% 171
2024
Q4 		$13M Sell
18,202
-1,440
-7% -$1.21M 0.09% 177
2024
Q3 		$20.7M Sell
19,642
-282
-1% -$314K 0.15% 119
2024
Q2 		$21M Buy
19,924
+398
+2% +$386K 0.17% 100
2024
Q1 		$18.8M Buy
19,526
+402
+2% +$382K 0.15% 121
2023
Q4 		$16.8M Sell
19,124
-889
-4% -$732K 0.15% 124
2023
Q3 		$16.5M Buy
20,013
+857
+4% +$674K 0.18% 116
2023
Q2 		$13.8M Buy
19,156
+253
+1% +$195K 0.16% 132
2023
Q1 		$15.5M Buy
18,903
+337
+2% +$254K 0.21% 104
2022
Q4 		$13.4M Buy
18,566
+358
+2% +$264K 0.19% 121
2022
Q3 		$12.6M Sell
18,208
-5,344
-23% -$3.36M 0.18% 121
2022
Q2 		$13.9M Sell
23,552
-1,577
-6% -$1.03M 0.14% 155
2022
Q1 		$17.6M Buy
25,129
+877
+4% +$555K 0.14% 148
2021
Q4 		$15.3M Hold
24,252
– – 0.12% 173
2021
Q3 		$14.7M Buy
24,252
+18,204
+301% +$11.3M 0.12% 168
2021
Q2 		$3.38M Hold
6,048
– – 0.03% 330
2021
Q1 		$2.86M Hold
6,048
– – 0.02% 344
2020
Q4 		$2.92M Sell
6,048
-700
-10% -$378K 0.03% 312
2020
Q3 		$3.78M Hold
6,748
– – 0.04% 259
2020
Q2 		$4.21M Buy
+6,748
New +$3.83M 0.04% 226

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

USS Investment Management's REGN Position: Q2 2026 in Review

USS Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 4% in Q2 2026, buying an estimated $548K and bringing the position to 21,035 shares worth $13.1M. The position accounts for 0.05% of the portfolio, ranked #243.

USS Investment Management first reported a position in REGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $21M in Q2 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • USS Investment Management held 21,035 shares of Regeneron Pharmaceuticals worth $13.1M as of Q2 2026.
  • USS Investment Management bought 805 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $548K.
  • Regeneron Pharmaceuticals made up 0.05% of USS Investment Management's portfolio in Q2 2026, its #243 holding.
  • USS Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • USS Investment Management's Regeneron Pharmaceuticals position peaked at $21M in Q2 2024.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.